Calgary Herald on MSN

Keenan: The latest Alzheimer’s wonder drug and how to avoid needing it

Health Canada recently approved lecanemab (brand name Leqembi®) to treat people with mild cognitive impairment or mild ...

VABYSMO® (faricimab injection) Pre-Filled Syringe Now Publicly Funded through Ontario Drug Benefit (ODB) Program

La Roche Limited (Roche Canada) is pleased to announce today that VABYSMO® (faricimab injection) Pre-Filled Syringe (PFS) is ...

ARS Pharma Launches Get neffy® on Us for Patients with Severe Allergic Reactions to Improve Access to neffy (epinephrine nasal spray)

Detailed price information for Ars Pharmaceuticals Inc (SPRY-Q) from The Globe and Mail including charting and trades.
The Canadian Press on MSN

Health Canada authorizes long-awaited drug to slow early-stage Alzheimer’s disease

TORONTO - Health Canada has authorized a drug shown to slow the progression of Alzheimer’s disease. Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in ...

Sandoz Group AG (SDZNY) Q3 2025 Sales Call Transcript

Q3 2025 Sales Call October 30, 2025 4:00 AM EDTCompany ParticipantsCraig Marks - Head of Investor RelationsRichard Saynor ...